Form 4: Genpact Director Mark Verdi Awarded 4,825 Restricted Share Units

Genpact Director Mark Verdi has been granted 4,825 unvested restricted share units, which will vest by December 31, 2025, and settle in common shares by December 31, 2026.

Summary

• Mark A. Verdi, a Director of Genpact LTD (ticker: G), acquired 4,825 common shares on May 22, 2025.
• These shares were acquired as an award of unvested restricted share units (RSUs) under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.
• Each RSU entitles the holder to receive one common share at a future date.
• The RSUs are subject to Mr. Verdi's continued service and will fully vest on December 31, 2025.
• The common shares resulting from the vested RSUs will be settled on December 31, 2026.
• Following this transaction, Mr. Verdi beneficially owns a total of 65,005 common shares.

Sentiment

Score: 7

Explanation: The grant of restricted share units to a director is a positive sign of alignment between management and shareholder interests, reflecting a standard compensation practice.

Positives

• The grant of 4,825 restricted share units to Director Mark A. Verdi aligns his interests with those of shareholders, as his compensation is tied to the company's future performance.
• The award is part of the Genpact Limited 2017 Omnibus Incentive Compensation Plan, indicating a structured and transparent approach to executive compensation.

Negatives

• No specific negative aspects are identified within this Form 4 filing, as the transaction represents a routine equity compensation grant.

Risks

• The vesting of the restricted share units is contingent upon the reporting person's continued service, meaning the shares could be forfeited if service ceases before the December 31, 2025 vesting date.

Future Outlook

The filing indicates future share settlement on December 31, 2026, contingent on vesting on December 31, 2025, which is tied to continued service. This reflects the company's long-term incentive structure for its directors.

Industry Context

The granting of restricted share units (RSUs) is a common practice in the technology and business process management (BPM) industries, including companies like Genpact, to attract, retain, and incentivize key executives and directors by aligning their long-term interests with shareholder value creation.

Comparison to Industry Standards

• The use of Restricted Share Units (RSUs) as a form of equity compensation is a standard practice across global industries, particularly in the professional services and IT consulting sectors where companies like Accenture, Cognizant, and Wipro also utilize similar long-term incentive plans to retain talent and align management with shareholder interests.
• The specific size of the grant (4,825 RSUs) would typically be evaluated against the director's overall compensation package and the company's performance, but this document alone does not provide enough context for a detailed comparative assessment of the grant size itself.

Corporate Governance

Related Party Transactions

• This filing reports an insider transaction, specifically an equity grant to a director, which is a form of related party dealing, though it is a standard compensation mechanism rather than an unusual transaction.

Stakeholder Impact

• Shareholders: The grant aligns the director's long-term interests with shareholder value creation, potentially leading to better governance and performance.
• Employees: While not directly impacting all employees, it signals the company's commitment to incentivizing key personnel through equity, which can contribute to overall talent retention strategies.

Next Steps

• Continued service of Mark A. Verdi until December 31, 2025, for the RSUs to fully vest.
• Settlement of the vested RSUs into common shares on December 31, 2026.

Key Dates

Keywords

Genpact, G, Form 4, SEC filing, insider transaction, restricted share units, RSU, equity compensation, director, Mark Verdi, beneficial ownership, corporate governance